Atlas FDA

Maestro Rechargeable System

FDA premarket approval P130019/S015 · decided 2018-01-24

Approval details

PMA number
P130019
Supplement
S015
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
Maestro Rechargeable System
Generic name
neuromodulator for obesity
Applicant
Reshape Lifesciences, Inc.
Date received
2017-06-08
Decision date
2018-01-24
Days to decision
230 days
Decision code
APPR
Product code
PIM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Roseville, MN
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.